Surgical treatment and outcome of pulmonary hamartoma: a retrospective study of 10-year experience
- 11 Downloads
The present retrospective study was designed to review the clinicopathological features and outcome of surgical treatment of pulmonary hamartoma who underwent surgical operation between January 2008 and January 2018.
The information about the age and gender of patients, symptoms, history of tobacco consumption, the presence of malignancies, radiological and imaging findings, calcification in the hamartoma, location and size of the lesions, findings of preoperative diagnostic investigations, operative procedures, operative time, tube drainage duration, surgical complication, hospital stay after tumor resection, duration of follow-up, and outcome were recorded.
The average size of the neoplasms was 2.72 cm. Five patients (20.8%) had malignancies, which occurred previously in two patients, and concomitantly in three patients. Twenty-four patients underwent surgical treatment which included enucleation in 14 (four cases had thoracoscopic surgery), wedge resection in 8 (six cases had thoracoscopic surgery), and lobectomy in 2 patients. A total of four postoperative complications were noted. The patients were followed up for 2–98 months.
Enucleation was the main choice in our series. The follow-up for a long period revealed no malignant transformation and recurrence. Due to lack of the malignance after operation in our series, we presumed that the enucleation for pulmonary hamartoma was safe enough.
KeywordsHamartoma Treatment Outcome
Compliance with ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Van den Bosch J, Wagenaar S, Corrin B, Elbers JR, Knaepen PJ, Westermann CJ. Mesenchymoma of the lung (so-called hamartoma): a review of 154 parenchymal and endobronchial cases. Thorax. 1987;42:790–3.Google Scholar
- 2.Gjevre JA, Myers JL, Prakash UB. Pulmonary hamartomas. Mayo Cline Proc. 1996;71:14–20.Google Scholar
- 4.Itoga M, Kobayashi Y, Takeda M, et al. A case of pulmonary hamartoma showing rapid growth. Case Rep Med. 2013;2013:231652. https://doi.org/10.1155/2013/231652.
- 6.Hansen CP, Holtveg H, Francis D, Rasch L, Bertelsen S. Pulmonary hamartoma. J Thorac Cardiovasc Surg. 1992;104:674–8.Google Scholar
- 8.Bergh NP, Hafstrom LO, Scherson T. Hamartoma of the lung: with special reference to the endobronchial localization. Scand J Respir Dis. 1967;48:201–7.Google Scholar
- 11.Ribet M, Jaillard-Thery S, Nuttens MC. Pulmonary hamartoma and malignancy. J Thorac Cardiovasc Surg. 1994;107:611–4.Google Scholar
- 13.Karasik A, Modan M, Jacob CO, Lieberman Y. Increased risk of lung cancer in patient with chondromatous hamartoma. J Thorac Cardiovasc Surg. 1980;80:217–20.Google Scholar
- 14.Guo W, Zhao YP, Jiang YG, Wang RW, Ma Z. Surgical treatment and outcome of pulmonary hamartoma: a retrospective study of 20-year experience. J Exp Clin Cancer Res. 2008;27:8. https://doi.org/10.1186/1756-9966-27-8.
- 18.Lien YC, Hsu HS, Li WY, et al. Pulmonary hamartoma. J Chin Med Assoc. 2004;67:21–6.Google Scholar